Review
doi: 10.1016/s1388-9842(02)00249-0.
Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure
Affiliations
- PMID: 12559221
- DOI: 10.1016/s1388-9842(02)00249-0
Item in Clipboard
Review
Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure
Eur J Heart Fail.
2003 Jan.
Free article
Abstract
This article continues a series of reports on research developments of particular interest to those involved in the management of patients with heart failure. Summaries of the following trials, reported at the 75th Scientific Sessions of the American Heart Association held in Chicago, Illinois between 17th and 20th November 2002 are included: PROSPER; DIAL; home care monitoring trials; immune modulation therapy; COMPANION; and anaemia in heart failure.
Similar articles
-
The 2005 Scientific Sessions of the American Heart Association (AHA).Heart Fail Monit. 2006;5(1):34-6. Heart Fail Monit. 2006. PMID: 16547528 No abstract available.
-
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF.Eur J Heart Fail. 2001 Aug;3(4):491-4. doi: 10.1016/s1388-9842(01)00175-1. Eur J Heart Fail. 2001. PMID: 11511436
-
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.Circulation. 2016 Sep 27;134(13):e282-93. doi: 10.1161/CIR.0000000000000435. Epub 2016 May 20. Circulation. 2016. PMID: 27208050 No abstract available.
-
Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association.Circulation. 2016 Feb 23;133(8):770-801. doi: 10.1161/CIR.0000000000000352. Epub 2016 Jan 19. Circulation. 2016. PMID: 26787728 Review. No abstract available.
-
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure.Eur J Heart Fail. 2004 Jun;6(4):501-8. doi: 10.1016/j.ejheart.2004.04.014. Eur J Heart Fail. 2004. PMID: 15182777 Review.
Cited by
-
Effects of therapy using the Celacade system on structural and functional cardiac remodelling in rats following myocardial infarction.Can J Cardiol. 2009 Jul;25(7):e241-7. doi: 10.1016/s0828-282x(09)70510-0. Can J Cardiol. 2009. PMID: 19584980 Free PMC article.
-
[New technologies in the optimization of CRT programming].Herzschrittmacherther Elektrophysiol. 2008 Mar;19(1):19-29. doi: 10.1007/s00399-008-0596-y. Herzschrittmacherther Elektrophysiol. 2008. PMID: 18330672 German.
-
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.BMC Nephrol. 2006 Mar 6;7:3. doi: 10.1186/1471-2369-7-3. BMC Nephrol. 2006. PMID: 16515712 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
